{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:21:17Z","timestamp":1768483277271,"version":"3.49.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,8]],"date-time":"2015-06-08T00:00:00Z","timestamp":1433721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0123967","type":"journal-article","created":{"date-parts":[[2015,6,8]],"date-time":"2015-06-08T18:07:56Z","timestamp":1433786876000},"page":"e0123967","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy"],"prefix":"10.1371","volume":"10","author":[{"given":"Bingbing","family":"Dai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto","family":"Lara-Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gitanjali","family":"Jayachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mourad","family":"Majidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Nebiyou","family":"Bekele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerabhadran","family":"Baladandayuthapani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suk-Young","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack A.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,6,8]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"e34833","DOI":"10.1371\/journal.pone.0034833","article-title":"Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans","volume":"7","author":"C Lu","year":"2012","journal-title":"PLoS One"},{"key":"ref2","first-page":"1949","article-title":"High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic\/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints","volume":"60","author":"II Wistuba","year":"2000","journal-title":"Cancer Research"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.physiol.64.081501.155828","article-title":"Molecular pathogenesis of lung cancer","volume":"64","author":"S Zochbauer-Muller","year":"2002","journal-title":"AnnuRev Physiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/14796694.1.1.79","article-title":"3p21.3 tumor suppressor cluster: prospects for translational applications","volume":"1","author":"L Ji","year":"2005","journal-title":"Future Oncology"},{"key":"ref5","first-page":"6116","article-title":"The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium","volume":"60","author":"MI Lerman","year":"2000","journal-title":"Cancer Research"},{"key":"ref6","first-page":"2715","article-title":"Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo","volume":"62","author":"L Ji","year":"2002","journal-title":"Cancer Research"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"6258","DOI":"10.1038\/sj.onc.1204832","article-title":"Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells","volume":"20","author":"M Kondo","year":"2001","journal-title":"Oncogene"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-03-3702","article-title":"Myristoylation of the FUS1 protein is required for tumor suppression in human lung cancer cells","volume":"64","author":"F Uno","year":"2004","journal-title":"Cancer Research"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1158\/0008-5472.CAN-06-3463","article-title":"Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells","volume":"67","author":"W Deng","year":"2007","journal-title":"Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.1038\/sj.onc.1210500","article-title":"Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: Inhibition of c-Abl by the tumor suppressor gene product Fus1","volume":"26","author":"J Lin","year":"2007","journal-title":"Oncogene"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/JTO.0b013e31816bce65","article-title":"Tumor suppressor FUS1 signaling pathway","volume":"3","author":"L Ji","year":"2008","journal-title":"J Thorac Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1470-2045(03)01137-9","article-title":"Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer","volume":"4","author":"SS Sridhar","year":"2003","journal-title":"Lancet Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa050753","article-title":"Erlotinib in previously treated non-small-cell lung cancer","volume":"353","author":"FA Shepherd","year":"2005","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1158\/1078-0432.CCR-06-0714","article-title":"Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib","volume":"12","author":"T Kosaka","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1158\/1078-0432.CCR-06-1570","article-title":"Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors","volume":"12","author":"MN Balak","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/JTO.0b013e31827ed0ff","article-title":"Epidermal growth factor receptor inhibition in lung cancer: status 2012","volume":"8","author":"FR Hirsch","year":"2013","journal-title":"J Thorac Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"TS Mok","year":"2009","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1200\/JCO.2010.33.4235","article-title":"Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin\/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS)","volume":"29","author":"M Fukuoka","year":"2011","journal-title":"J Clin Oncol"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"e14117","DOI":"10.1371\/journal.pone.0014117","article-title":"Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression","volume":"5","author":"KE Ware","year":"2010","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1158\/1078-0432.CCR-07-1252","article-title":"Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer","volume":"14","author":"L Prudkin","year":"2008","journal-title":"Clinical Cancer Research"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/sj.cgt.7700756","article-title":"Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo","volume":"11","author":"I Ito","year":"2004","journal-title":"Cancer Gene Therapy"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"C Kandoth","year":"2013","journal-title":"Nature"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"e77067","DOI":"10.1371\/journal.pone.0077067","article-title":"The tumor suppressor gene TUSC2 (FUS1) sensitizes NSCLC to the AKT inhibitor MK2206 in LKB1-dependent manner","volume":"8","author":"J Meng","year":"2013","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1158\/1535-7163.MCT-06-0166","article-title":"Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non-small-cell lung, pancreatic, colon, and breast tumors","volume":"5","author":"E Buck","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/sj.gt.3300485","article-title":"Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA","volume":"4","author":"JP Yang","year":"1997","journal-title":"Gene Therapy"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nbt0797-647","article-title":"Improved DNA: liposome complexes for increased systemic delivery and gene expression","volume":"15","author":"NS Templeton","year":"1997","journal-title":"Nat Biotechnol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1089\/hum.2005.16.1087","article-title":"Reversible mode of binding of serum proteins to DOTAP\/cholesterol Lipoplexes: a possible explanation for intravenous lipofection efficiency","volume":"16","author":"D Simberg","year":"2005","journal-title":"Human Gene Therapy"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1073\/pnas.0610298104","article-title":"Biomimetic amplification of nanoparticle homing to tumors","volume":"104","author":"D Simberg","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1089\/hum.1996.7.9-1111","article-title":"In vitro and in vivo liposome-mediated gene transfer leads to human MDR1 expression in mouse bone marrow progenitor cells","volume":"7","author":"I Aksentijevich","year":"1996","journal-title":"Human Gene Therapy"},{"key":"ref30","first-page":"409","article-title":"Increased uptake of liposomal-DNA complex by lung metastasis following intravenous administration","volume":"7","author":"I Ito","year":"2003","journal-title":"MolTher"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.gt.3301640","article-title":"Potential limitations of transcription terminators used as transgene insulators in adenoviral vectors","volume":"9","author":"M Buvoli","year":"2002","journal-title":"Gene Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1093\/nar\/20.9.2233","article-title":"Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector","volume":"20","author":"GW Wilkinson","year":"1992","journal-title":"Nucleic Acids Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0123967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T20:46:36Z","timestamp":1540241196000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0123967"}},"subtitle":[],"editor":[{"given":"Wafik S.","family":"El-Deiry","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,8]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0123967","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,8]]}}}